Richard Beckman

Company: Adverum

Job title: Chief Medical Officer

Seminars:

Showcasing ADVM-022 as a Treatment for Neovascular AMD 9:30 am

Wet AMD: the rationale for using gene therapy for treatment Utilizing aAV.7m8 vector for intravitreal administration and preclinical and clinical support for dosing Clinical experience with ADVM-022 in Wet AMDRead more

day: Day Two